Palvella Therapeutics COO Kathleen Goin reports sale of 4,302 common shares worth $654,184.41

• Palvella Therapeutics COO Kathleen Goin exercised stock options on Aug. 19, 2026, acquiring 4,302 common shares at USD 7.14–9.08.
• She sold 4,302 common shares the same day at weighted-average prices around USD 151.39–156.77.
• Her direct common stock ownership fell to zero following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-099222), on August 20, 2026, and is solely responsible for the information contained therein.